About Us

BabySafe Newborn Screening

BabySafe screens newborn babies for Inherited Metabolic Diseases (IEM). IEM are genetic diseases caused by defective proteins, which are essential for metabolic reactions.

The development and advancement of key technologies such as tandem mass spectrometry allows for effective detection of metabolic disorders, some of which are potentially fatal conditions that are not apparent at birth.

Newborn screening (NBS) programs are an integral part of healthcare services in countries around the world. Such programs are implemented in countries such as the United States, United Kingdom, Australia and Singapore to list a few.

Early detection of these diseases is important for early treatment and prevention of severe health problems such as mental retardation or even mortality.

Liquid chromatography–mass spectrometry (LC-MS) is an analytical chemistry technique which is widely used to analyze biochemical, organic, and inorganic compounds.
Established since 2007, Synapse Laboratory has been providing medical testing services including DNA / RNA tests and genetic testing for newborns.

Our success resides in the dedication and commitment of our workforce.

Technology Partners

Synapse Laboratory partners with market-leaders in newborn screening and facilitate innovative new technologies to offer unique screening and diagnostic solutions.